CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages

Figure 1

ROC curve analysis of the diagnostic values of CA125 and HE4 levels and ROMA and CPH-I indices for BOT I+II and EOC I+II of all patients (a), premenopausal patients (b), and postmenopausal patients (c). Abbreviations: Pre-M = premenopausal; Post-M = postmenopausal;  = AUC-ROC; ^a, ^b, and ^c =  value of AUC-ROC compared with CA125, HE4, and ROMA, respectively.

(a)

(b)

(c)